Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 113

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 1
Chunk 113
---
 Company must either (i) consummate
a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company and
one or more businesses or entities or (ii) cease its operations, except for the purpose of winding up, if it fails to complete such initial
business combination and redeem 100% of the Company’s Class A ordinary shares, included as part of the units sold in the Company’s
IPO that was consummated on April 11, 2022 from April 11, 2025 to December 11, 2025, by electing to extend the date to consummate an initial
business combination on a monthly basis for up to eight (8) times by an additional one month each time, unless the closing of the Company’s
initial business combination has occurred, without the need for any further approval of the Company’s shareholders, provided that
the Sponsor (or its affiliates or permitted designees or a third party) will deposit into the Trust Account for each such one-month extension
an extension fee, unless the closing of the Company’s initial business combination has occurred, in exchange for a non-interest
bearing promissory note payable upon consummation of an initial business combination.

F-29

EXHIBIT
INDEX

    Exhibit
     
    Description
  
    1.1
     
    Underwriting Agreement, dated April 6, 2022, among the Company, US Tiger Securities, Inc. and EF Hutton, division of Benchmark Investments, LLC, as representatives of the several underwriters named therein(2)
  
    2.1#
     
    Agreement and Plan of Merger, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.(9)
  
    3.1
     
    Amended and Restated Memorandum and Articles of Association, dated April 6, 2022(2)
  
    3.2
     
    Amendments to the Amended and Restated Memorandum and Articles of Association in connection with the Extension Meeting(3)
  
    3.3
     
    Amendments to the Amended and Restated Memorandum and Articles of Association in connection with the Second Extension Meeting(8)
  
    4.1
     
    Specimen Unit Certificate(1)
  
    4.2
     
    Spec